butch228

Papa to two handsome boys, Primary Care Nurse Practitioner. Pinoy living in Boston with husband , 2kids, a dog and a cat.

[Dr. AK 🇮🇳 @docakx]

Pancreatic cancer is the most lethal human cancer with an overall 5-year survival of 13%. Most patients relate that they have had developing symptoms over months to years before diagnosis.

Here are the earliest symptoms

1. Pale floating stools that are hard to flush.

[Keith Siau @drkeithsiau]

A patient on longstanding omeprazole was admitted with severe fatigue. What do you think we found?

[江樾禾 @feihuo17]

中国小姐姐沉浸式洗碗不仅节省用水、还洗得干净彻底的视频在外网上火了。有网友说，这视频应该作为全世界的洗碗教科书来用😆

[Muscle Blueprint - Fitness | Health | Abs @MuscleB1ueprint]

Easy flat tummy workout ! 🔥

[Muscle Hub @MusclezHub]

8 DB Only Back Workout:

1.

[MEDICINE MADNESS @Doctors_GUILD]

Important table of Electrolyte Imbalance
Save it for quick revision

[Oren Gottfried, MD @OGdukeneurosurg]

Heart failure w reduced ejection fractions

[Meded Daily @MededDaily42640]

PER VAGINAL EXAMINATION (PVE)

[Dr M Shujat Rasool @DrMShujat]

Clinical Approach to Dizziness For Residents| House officers |MOs:

Dizziness is a symptom, not a diagnosis. The key to solving it is determining what the patient actually means by “dizzy.”

[Fitness Workout @Fitnesswork_out]

2 min to get big glutes at home.

[Tehxi @yajnshri]

5 Exercises that reverse aging.

[Dr. Priyam Bordoloi @DocPriyamMD]

Med students, listen up! Today let me explain how to analyze a Liver Function Test (LFT) step by step.
​Stop looking at isolated HIGH or LOW flags on a lab report. You need to look at the patterns. Here is how you actually read an LFT panel like a CONSULTANT 👇 (1/10)

[Forge Physique @ForgePhysique]

All You Need Is One Kettlebell

[Afshine Emrani MD FACC @afshineemrani]

I'm a cardiologist. After 40, stop guessing about your health. These numbers tell you whether you're building a long, vibrant life — or quietly declining without knowing it.

I run these on myself. I run them on every patient I care about. Most are cheap bloodwork. All are available now. And together, they paint a picture no standard annual physical will ever give you. Print this. Bring it to your next appointment. Your 60-year-old self will thank you.
ꟷꟷꟷ
𝗙𝗮𝘀𝘁𝗶𝗻𝗴 𝗜𝗻𝘀𝘂𝗹𝗶𝗻
Target: below 5 μIU/mL. Ideal: 3-4.
This is the 10-year warning bell your standard panel completely misses. Your glucose and A1c can look "normal" for a decade while your pancreas is working overtime to keep them there. Fasting insulin catches insulin resistance 5-10 years before your A1c moves. By the time A1c rises, the damage is already extensive.

𝗛𝗢𝗠𝗔-𝗜𝗥
Target: below 1.0.
Calculated from fasting insulin and fasting glucose. The single best measure of insulin sensitivity. Above 1.0 and your metabolism is already under strain. Above 2.5 and you're insulin resistant — even if every other number looks fine.

𝗛𝗯𝗔𝟭𝗰
Target: below 5.4%.
Not below 5.7% — that's the threshold where medicine calls you "prediabetic." By then you've been metabolically compromised for years. Optimal is below 5.4%. Blood sugar mastery is longevity mastery.

𝗧𝗿𝗶𝗴𝗹𝘆𝗰𝗲𝗿𝗶𝗱𝗲 : 𝗛𝗗𝗟 𝗥𝗮𝘁𝗶𝗼
Target: below 2. Ideal: below 1.
Your metabolic health crystal ball. This ratio predicts insulin resistance, cardiovascular risk, and metabolic syndrome better than any single lipid number alone. A ratio above 3.5 is a red flag regardless of what your total cholesterol says.

𝗔𝗽𝗼𝗕
Target: below 80 mg/dL for moderate risk. Below 60 for high risk.
I've written about this extensively. ApoB counts every atherogenic particle hitting your artery walls. A 2024 analysis found 54% of patients had dangerous levels that standard LDL testing completely missed. If you only know your LDL, you're driving with one eye closed.

𝗟𝗽(𝗮)
Test once in your lifetime.
100% genetic. 1 in 5 Americans are elevated. Triples heart attack risk independently of everything else on this list. Diet and exercise cannot lower it. The 2026 ACC/AHA guidelines now recommend everyone be tested. Most never have been.

𝗵𝘀-𝗖𝗥𝗣
Target: below 1.0 mg/L.
You can have perfect cholesterol and inflamed arteries silently preparing to rupture. hs-CRP measures the fire behind the plaque. The JUPITER trial proved that finding and treating inflammation saves lives — even when lipids look fine. If this number is elevated, your mouth, your gut, your metabolic health, and your visceral fat are the first places to investigate.

𝗩𝗶𝘁𝗮𝗺𝗶𝗻 𝗗
Target: 50-80 ng/mL.
Not the bare minimum of 30 your doctor accepts. Suboptimal vitamin D is linked to higher inflammation, weaker immunity, increased cardiovascular events, worse mood, and poorer outcomes across nearly every disease I treat. Supplement D3 with K2 — without K2, calcium deposits in your arteries instead of your bones.

𝗧𝗲𝘀𝘁𝗼𝘀𝘁𝗲𝗿𝗼𝗻𝗲 (𝗧𝗼𝘁𝗮𝗹 + 𝗙𝗿𝗲𝗲)
Men: optimal range 600-1000+ ng/dL total.
Declining testosterone is an independent predictor of cardiovascular death in men. It's tied to insulin resistance, arterial stiffness, visceral fat accumulation, and systemic inflammation. DHEA-S drops 10-20% every decade after 30. Tracking these isn't about vanity — it's evaluating your body's systemic resilience.

𝗕𝗹𝗼𝗼𝗱 𝗣𝗿𝗲𝘀𝘀𝘂𝗿𝗲
Target: below 120/80. Aim closer to 110/70.
Every point above optimal is cumulative arterial damage. Buy a home cuff. Measure morning and evening, seated quietly for five minutes, arm at heart level. White-coat readings in the office miss what's really happening. The smartest $40 investment in cardiac self-care.

𝗩𝗢𝟮 𝗠𝗮𝘅
Men over 40: above 40 mL/kg/min. Women over 40: above 35.
Cardiorespiratory fitness is the single strongest predictor of all-cause mortality — stronger than smoking, diabetes, or heart disease as individual risk factors. A landmark study in JAMA found that extreme fitness was associated with the lowest mortality with no upper limit of benefit. You can estimate VO2 max with a timed mile, a rower test, or a wearable. Get faster every year.

𝗡𝘂𝗺𝗯𝗲𝗿 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀
Target: as few as possible.
Every medication you're on should be earning its place. I just wrote about five commonly prescribed drugs that do more harm than good with long-term use. Bring your full medication list to every appointment. Ask: "Do I still need this?" Deprescribing is one of the most powerful and underused tools in medicine.
ꟷꟷꟷ

Thirteen numbers. Most available through cheap bloodwork and simple tests. Get them once or twice a year. Here's what I want you to understand: these numbers don't just tell you where you are. They tell you where you're heading. A fasting insulin of 8 today becomes diabetes in five years. An ApoB of 120 today becomes a heart attack in ten. An hs-CRP of 3 today means your arteries are inflamed right now — regardless of how healthy you feel. The standard annual physical checks a fraction of these. It was designed to find disease that's already there. This panel finds the disease that's coming — years before it arrives.

What gets measured gets improved. Optimize with the foundation I write about every week on this platform:
Zone 2 cardio plus resistance training 3-4 times per week. High-protein whole-food nutrition. Sleep 7-9 hours — non-negotiable. Morning sunlight. Stress management. And the targeted supplements I've covered in detail — creatine, magnesium, CoQ10, D3+K2, glycine, omega-3, psyllium husk.
The breakthroughs coming in the next decade — gene editing for cholesterol, cellular reprogramming, senolytics that clear senescent "zombie" cells driving inflammation and aging, GLP-1 drugs rewriting metabolic medicine — will be most powerful for people who've already built the metabolic foundation to receive them.

The future of medicine is personalized. But it starts with knowing your numbers today. Print this list. Book the bloodwork. Own the data. Prevention isn't passive. It's the most aggressive thing you can do for the decades ahead.

[Fitness Workout @Fitnesswork_out]

Beginner Chest Workout at Home

[Karl Matt Button │ Apex Fitness Adv. @KarlApexFit]

If I had to get in the best shape of my life with nothing but dumbbells and a bench...

Back. Chest. Legs. Shoulders. Arms.

All of it. Covered.

Here are the exact 11 exercises I'd choose:

= Thread =

[Afshine Emrani MD FACC @afshineemrani]

I'm a cardiologist. NPR reported this morning on something that could save more lives than any drug I've ever prescribed.

One blood test. One vial. Screening for 50 different cancers simultaneously.

It's called Galleri. And the FDA could approve it later this year.

Right now, we routinely screen for exactly five cancers in the United States — breast, colon, cervical, prostate, and lung. Each requires its own separate scan or exam. For the rest — pancreatic cancer, ovarian cancer, liver cancer, esophageal cancer, gastric cancer, and dozens more — we have no routine screening at all. We find them when symptoms appear. By then, most are Stage 3 or 4. By then, for many patients, it's too late.

Pancreatic cancer has a 12% five-year survival rate — because we almost always catch it late. Ovarian cancer: 50%. Liver cancer: 21%. These numbers aren't medical failures. They're detection failures. The treatments exist. We just find the disease after the window for those treatments has closed.

Galleri changes the math entirely.

Here's how it works. Every tumor — no matter where it is in your body — sheds tiny fragments of DNA into your bloodstream as cancer cells die and divide. These fragments carry specific methylation patterns — chemical signatures that are unique to cancer cells and different from the DNA your healthy cells release.
Galleri captures these fragments from a standard blood draw and reads their methylation patterns using next-generation sequencing and AI-driven analysis. The AI doesn't just detect whether cancer is present. It predicts where it's coming from — which organ, which tissue type — with over 90% accuracy in studies. One vial of blood tells your doctor: there's a cancer signal, and it's likely originating in your pancreas, or your lung, or your liver.

Your physician then orders targeted follow-up imaging to confirm or rule out the finding. Galleri isn't a diagnosis. It's a precision compass that tells your doctor exactly where to look.

The data is building fast.

GRAIL has now sold over 475,000 Galleri tests commercially under a special FDA designation. The NHS-Galleri trial — the largest randomized controlled trial of any multi-cancer detection test in history — enrolled over 142,000 people aged 50-77 in England. The primary endpoint — an overall reduction in late-stage cancers — was not met. But by the third year of annual screening, they found a 26% reduction in Stage IV cancers in key deadly types including pancreatic, liver, lung, and gastric. The test detected four times more cancers overall when added to standard screening — catching cancers that would otherwise have been found late or not at all.

The U.S. Pathfinder 2 study — 25,490 participants — showed similar positive signals and forms the basis of the FDA submission filed in January 2026.
Congress has already acted. The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act passed in February. If the FDA approves Galleri, Medicare will begin covering one test per year starting in 2028.

The current retail price is $950. Exact Sciences' competing test Cancerguard is $659. These prices will fall dramatically once FDA approval triggers insurance coverage and competition scales.

As a cardiologist, let me tell you why this matters far beyond oncology.

Cancer is now the number one killer of Americans over 50. Not heart disease. Cancer. And the patients I lose to cancer are often the same patients whose hearts I saved — patients who survived their cardiac event, optimized their metabolic health, and then received a late-stage cancer diagnosis that nobody screened for because no screening tool existed.

I've written on this platform about GLP-1 drugs reducing cancer metastasis by up to 50%. About personalized mRNA cancer vaccines cutting recurrence by 49%. About inflammation as the common root of heart disease and cancer. About AI detecting disease years before symptoms.

Galleri is the missing piece that connects all of it.
Detect the cancer early — with a blood test. Confirm it with AI-enhanced imaging. Treat it with personalized mRNA vaccines, targeted therapy, and GLP-1 drugs that may slow progression. Monitor response with liquid biopsy in real time.

That's not five separate breakthroughs. That's one integrated system of cancer prevention and treatment that didn't exist five years ago — and could be standard of care within five more.

The shift from reactive to proactive medicine — from "we found it too late" to "we caught it in time" — has been the central theme of everything I've written on this platform. Preventive cardiology. Advanced lipid testing. Inflammation detection. AI imaging. Gene editing.

Galleri applies the same principle to cancer. And it could save more lives than all of them combined.

One blood test. Fifty cancers. FDA decision expected this year.

Prevention is the new cure. And the science just took its biggest step yet.

https://t.co/2crrETWhRa

[Dr Jason Philip. M.S., MCh @Jasonphilip8]

A 26 yr old man was once referred to me from the General Medicine Dept, with a BP reading of 220/130 mmHg. His presenting complaint was Headache. S.Creatinine- Normal. No family history of hypertension. No Diabetes. Ultrasound of the kidney was normal. Urine exam- Normal. Amlodipine, Telmisartan & Metaprolol had failed to reduce his BP. I diagnosed & cured his hypertension. Diagnosis? Treatment? Thoughts?
#Urology #MedicalStudents
#Hypertension